Gordon Research Conferences
Meeting Details

New Antibacterial Discovery & Development (GRS)
Gordon-Kenan Research Seminar

Enabling the Next Generation of Antibacterial Drugs


March 12-13, 2016


Renaissance Tuscany Il Ciocco
Lucca (Barga), Italy


David F. Bruhn & Daniel Hoagland

Meeting Description

The Gordon Research Seminar on New Antibacterial Discovery and Development is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

The discovery and development of new antibiotics to overcome the challenges presented by the rising incidence of drug-resistant bacteria requires the training of outstanding future leaders and the support of a rigorous scientific community. This meeting will enable students and early-career scientists to expand their knowledge and professional network in the field of antibiotic drug discovery and development through a series of research presentations by trainees and a mentorship component led by global experts in the field.

Related Meeting

This GRS was held in conjunction with the "New Antibacterial Discovery & Development" Gordon Research Conference (GRC). Refer to the associated GRC program page for more information.


Final Meeting Program

1:30 pm - 4:30 pmArrival and Check-in
3:00 pm - 3:15 pmIntroductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair
3:15 pm - 4:00 pmHow to Qualify a Drug Candidate for Development
Discussion Leader: Matthew Surdel (Vanderbilt University, USA)
3:15 pm - 3:50 pmLynn Silver (LL Silver Consulting, LLC, USA)
"How to Qualify a Drug Candidate for Development"
3:50 pm - 4:00 pmDiscussion
4:00 pm - 5:30 pmPoster Session
5:30 pm - 7:30 pmEarly Discovery and Mechanism of Action Studies
Discussion Leaders: Linda Oyama (Aberystwyth University, United Kingdom) and Marina Santiago (Harvard University, USA)
5:30 pm - 5:45 pmRenee Bouley (University of Notre Dame, USA)
"Exploration of the Mechanism of Action and Structure-Activity Relationship for a New Class of Quinazolinone Antibiotics"
5:45 pm - 5:50 pmDiscussion
5:50 pm - 6:05 pmJennifer Stepanek (Ruhr-University Bochum, Germany)
"Dual Mechanism of Action of the Atypical Tetracycline Chelocardin"
6:05 pm - 6:10 pmDiscussion
6:10 pm - 6:25 pmMichaela Wenzel (University of Amsterdam, The Netherlands)
"Reorganization of Fluid Lipid Domains by Daptomycin Inhibits Bacterial Cell Wall Synthesis"
6:25 pm - 6:30 pmDiscussion
6:30 pm - 6:45 pmAshleigh Paparella (The University of Adelaide, Australia)
"Template Guided Synthesis Provides New Antibacterials and Antifungals"
6:45 pm - 6:50 pmDiscussion
6:50 pm - 7:05 pmAndrew Lim (University of Dundee, United Kingdom)
"Mug the Bug: Applying Phenotypic Screening and Metabolomics in the Search for Novel Antibacterials"
7:05 pm - 7:10 pmDiscussion
7:10 pm - 7:25 pmBradley Poulsen (Massachussetts General Hospital / Broad Institute, Harvard Medical School, USA)
"A Multiplexed Chemical Screen of Pseudomonas aeruginosa Hypomorphs Rapidly Identifies Novel Antibiotic Leads"
7:25 pm - 7:30 pmDiscussion
8:00 pmDinner
7:30 am - 8:30 amBreakfast
9:00 am - 11:00 amAchieving, Maintaining, and Restoring Compound Efficacy
Discussion Leader: Philip Bulterys (University of California, Los Angeles, USA)
9:00 am - 9:45 amUrsula Theuretzbacher (Center for Anti-Infective Agents, Austria)
"Understanding PK/PD in Early Antibiotic R&D"
9:45 am - 10:00 amDiscussion
10:00 am - 10:15 amBimal Jana (University of Copenhagen, Denmark)
"Gene-Antimicrobial Drug Interactome of MDR Klebsiella pneumoniae ST258"
10:15 am - 10:20 amDiscussion
10:20 am - 10:35 amGiulia Orazi (Geisel School of Medicine, Dartmouth College, USA)
"Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection"
10:35 am - 10:40 amDiscussion
10:40 am - 10:55 amRyan Lamers (McMaster University, Canada)
"Reversing Beta-Lactam Resistance in Pseudomonas aeruginosa: A High-Throughput Screen for Inhibitors of Peptidoglycan Recycling"
10:55 am - 11:00 amDiscussion
11:00 am - 12:30 pmPoster Session

Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pmLunch
1:30 pm - 2:30 pmMentorship Component: Insights from the Industry
Discussion Leader: Miranda Jarrett (St. Jude Children's Research Hospital, USA)
1:30 pm - 2:30 pmPanel Discussion
"Lessons Learned from a Career in Drug Discovery and Development"
  • Michael Dudley (The Medicines Company, USA)
  • Lynn Silver (LL Silver Consulting, LLC, USA)
2:30 pm - 3:00 pmEvaluation Period
Fill in GRS Evaluation Forms
3:00 pmSeminar Concludes

Funding for this conference was made possible [in part] by 1 R13 AI 122053 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
© 2017 Gordon Research Conferences Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter